Amitriptyline for irritable bowel syndrome

  1. Gastrointestinal Expert Group. Therapeutic guidelines: Irritable bowel syndrome in adults. Melbourne: Therapeutic Guidelines Limited; 2022.
  2. Ford A, Wright-Hughes A, Alderson S, et al. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2023;402(10414):1773–85.
  3. Cleveland Clinic. Irritable Bowel Syndrome: Symptoms, Causes & Treatment: Cleveland Clinic; 2023. At: https://my.clevelandclinic.org/health/diseases/4342-irritable-bowel-syndrome-ibs
  4. Australian Medicines Handbook. Australian Medicines Handbook – Rifaximin: Australian Medicines Handbook Pty Ltd; 2023.
  5. Cleveland Clinic. Visceral hypersensitivity: symptoms, treatment, causes & what it is: Cleveland Clinic; 2022 At: https://my.clevelandclinic.org/health/diseases/22997-visceral-hypersensitivity.
  6. Australian Medicines Handbook. Australian medicines handbook – Amitriptyline: Australian Medicines Handbook Pty Ltd; 2023.